CapVest Partners agreed to buy a majority stake in Stada Arzneimittel AG, ending the long-running saga over the future of the German drugmaker. The deal valued Stada at about €10 billion ($11.7 billion) including debt, people familiar with the transaction said before it was announced.
www.bloomberg.com
#CapVest #Agrees #Buy #Majority #Stake #German #Drugmaker #Stada
CapVest Agrees to Buy Majority Stake in German Drugmaker Stada
